對(duì)比增強(qiáng)磁共振對(duì)缺血性心臟病與原發(fā)性擴(kuò)張型心肌病的臨床鑒別研究
本文關(guān)鍵詞: 對(duì)比增強(qiáng)磁共振 缺血性心臟病 擴(kuò)張型心肌病 延遲強(qiáng)化 出處:《北京協(xié)和醫(yī)學(xué)院》2014年碩士論文 論文類型:學(xué)位論文
【摘要】:目的:探討對(duì)比增強(qiáng)磁共振(CE-CMR)在缺血性心臟病和原發(fā)性擴(kuò)張型心肌病的臨床鑒別診斷中的作用。方法:選取2008年1月至2012年8月于我院行對(duì)比劑增強(qiáng)磁共振檢查和冠狀動(dòng)脈造影檢查,伴有左室擴(kuò)張和收縮功能減低的患者102例,分為兩組:28例擴(kuò)張型心肌病組與74例缺血性心臟病組,觀察左室壁心肌延遲強(qiáng)化的部位、程度及范圍。圖像分析:由兩位放射科醫(yī)師行盲法共同觀察分析,以意見一致為評(píng)判指標(biāo)。左室心肌分段采用美國心臟協(xié)會(huì)(AHA)左室壁17節(jié)段分段標(biāo)準(zhǔn)。心肌強(qiáng)化程度采用5分法:0分,無強(qiáng)化;1分,1-25%左室壁厚度強(qiáng)化;2分,26-50%左室壁厚度強(qiáng)化;3分,51-75%左室壁厚度強(qiáng)化;4分,76-100%左室壁厚度強(qiáng)化。室壁增厚率在心臟短軸位上進(jìn)行測(cè)量,以收縮末期心肌厚度減去舒張末期心肌厚度,以同層面病變部位對(duì)側(cè)心肌為正常對(duì)照。數(shù)據(jù)統(tǒng)計(jì):數(shù)據(jù)分析采用SPSS16.0統(tǒng)計(jì)分析軟件。兩組間的數(shù)據(jù)對(duì)比采用非配對(duì)t檢驗(yàn)和卡方檢驗(yàn)。P0.05被認(rèn)為有統(tǒng)計(jì)學(xué)意義。結(jié)果:擴(kuò)張型心肌病組對(duì)比劑增強(qiáng)磁共振掃描結(jié)果:8例患者可見左室壁延遲強(qiáng)化,其中1例為心內(nèi)膜下強(qiáng)化,3例為肌壁間強(qiáng)化,3例為散在強(qiáng)化,1例為斑片狀強(qiáng)化。缺血性心臟病組對(duì)比增強(qiáng)磁共振掃描結(jié)果:66例患者可見左室壁延遲強(qiáng)化,其中58例為透壁性強(qiáng)化,7例為心內(nèi)膜下強(qiáng)化。兩組間延遲強(qiáng)化的病例數(shù)有顯著差異(8:66,P0.001)。對(duì)于102例患者總體而言,CMR檢測(cè)到沿冠脈血管走行分布區(qū)域的典型的缺血性的透壁性或心內(nèi)膜下的延遲強(qiáng)化敏感度達(dá)到89%,而特異性達(dá)到98.5%。結(jié)論:磁共振延遲增強(qiáng)是鑒別擴(kuò)張型心臟病與缺血性心肌病的有效手段,與冠脈造影檢查相結(jié)合為二者間的鑒別提供了重要的參考價(jià)值。
[Abstract]:Objective: to investigate the role of contrast-enhanced magnetic resonance imaging (CE-CMR) in the differential diagnosis of ischemic heart disease and primary dilated cardiomyopathy. And coronary angiography, 102 patients with left ventricular dilatation and decreased systolic function were divided into two groups: dilated cardiomyopathy group (n = 28) and ischemic heart disease group (n = 74). Extent and scope. Image analysis: blind observation and analysis by two radiologists, According to consensus, the left ventricular myocardial segment was divided by the American Heart Association (AHA), the left ventricular wall was divided into 17 segments, and the degree of myocardial enhancement was measured by 5 points method: 0 points. No enhancement; 1-25% enhancement of left ventricular wall thickness; 2min 26-50% enhancement of left ventricular wall thickness; 51-75% enhancement of left ventricular wall thickness; 76-100% enhancement of left ventricular wall thickness; Subtracting end-diastolic myocardial thickness from end-systolic myocardial thickness, The contralateral myocardium of the same lesion was taken as the normal control. Data statistics: the data analysis was performed with SPSS16.0 software. The data contrast between the two groups was considered to be statistically significant by using unpaired t test and chi-square test. Results: contrast enhanced magnetic resonance imaging in dilated cardiomyopathy group showed delayed enhancement of left ventricular wall in 8 patients with dilated cardiomyopathy. One case was subendocardial enhancement, 3 cases were intramural enhancement, 3 cases were scattered enhancement, 1 case was patch enhancement. Contrast enhanced MRI showed delayed enhancement of left ventricular wall in 66 cases in ischemic heart disease group. Among them, 58 cases were transmural enhancement and 7 cases were subendocardial enhancement. There was a significant difference between the two groups in the number of patients with delayed enhancement. The sensitivity of transmural or subendocardial delayed enhancement was 89 and the specificity was 98.5.Conclusion: Mr delayed enhancement is an effective method for differentiating dilated heart disease from ischemic cardiomyopathy. The combination of coronary angiography and coronary angiography provides an important reference value for the differential diagnosis between the two.
【學(xué)位授予單位】:北京協(xié)和醫(yī)學(xué)院
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2014
【分類號(hào)】:R541;R445.2;R542.2
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 萬俊義;趙世華;;心臟磁共振釓對(duì)比劑延遲強(qiáng)化的臨床意義及判斷預(yù)后的價(jià)值[J];中國醫(yī)學(xué)影像技術(shù);2012年08期
2 尹剛;趙世華;陸敏杰;程懷兵;馬寧;趙濤;;磁共振自由呼吸三維延遲強(qiáng)化序列探測(cè)左室瘢痕的初步臨床應(yīng)用[J];磁共振成像;2011年03期
3 張青;王振常;趙波;鮮軍舫;田其昌;張華;吳超;李巖;羅福燕;牛延濤;史旭波;;心臟磁共振延遲強(qiáng)化成像定量評(píng)價(jià)心肌梗死的研究[J];臨床薈萃;2007年10期
4 Tandri H. ,Saranathan M. ,Rodriguez E.R. ,郝華;采用延遲強(qiáng)化磁共振成像術(shù)非侵入性檢測(cè)致心律失常性右室心肌病患者的心肌纖維化[J];世界核心醫(yī)學(xué)期刊文摘(心臟病學(xué)分冊(cè));2005年05期
5 C.J.Harrigan;D.C.Peters;C.M.Gibson;B.J.Maron;W.J.Manning;M.S.Maron;王鶴;;肥厚性心肌病:對(duì)比劑增強(qiáng)心血管MRI延遲強(qiáng)化定量分析[J];國際醫(yī)學(xué)放射學(xué)雜志;2011年02期
6 G.A.Krombach;C.Hahnen;K.Lodemann;N.Kramer;F.Schoth;M.Neizel;楊綺華;;Gd-BOPTA在MRI心肌活性評(píng)估中的作用:T_1值的變化及其對(duì)延遲強(qiáng)化的影響[J];國際醫(yī)學(xué)放射學(xué)雜志;2009年06期
7 林松柏;張竹花;李冬晶;張抒揚(yáng);陳黎波;馮逢;金征宇;;缺血性和非缺血性心臟病患者心肌病變磁共振心肌延遲強(qiáng)化的影像學(xué)特征比較[J];中國醫(yī)學(xué)科學(xué)院學(xué)報(bào);2009年01期
8 Naβenstein K;Bruder O;Breuckmann F;楊岷;;主動(dòng)脈瓣狹窄所致左心室肥厚患者心肌延遲強(qiáng)化的發(fā)生率、方式及與心室功能的關(guān)系[J];放射學(xué)實(shí)踐;2009年07期
9 周艷艷;張鋒;蔣文山;李平;;延遲強(qiáng)化條件下不同時(shí)相海洛因戒除者的行為沖動(dòng)性[J];中國藥物依賴性雜志;2008年04期
10 ;[J];;年期
相關(guān)會(huì)議論文 前3條
1 王振平;孔祥泉;劉穎;;MRI心肌灌注與延遲強(qiáng)化在心臟腫瘤診斷中的價(jià)值初探[A];2009中華醫(yī)學(xué)會(huì)影像技術(shù)分會(huì)第十七次全國學(xué)術(shù)大會(huì)論文集[C];2009年
2 尹剛;趙世華;陸敏杰;程懷兵;馬寧;安婧;趙濤;陳瑤;韓磊;王宏宇;吳言伶;楊新令;劉晶;殷小榮;;磁共振自由呼吸三維延遲強(qiáng)化序列探測(cè)左室瘢痕的臨床應(yīng)用[A];中華醫(yī)學(xué)會(huì)第十八次全國放射學(xué)學(xué)術(shù)會(huì)議論文匯編[C];2011年
3 尹剛;趙世華;陸敏杰;程懷兵;馬寧;張巖;凌堅(jiān);安婧;趙濤;陳瑤;韓磊;王宏宇;吳言伶;楊新令;劉晶;殷小榮;;磁共振自由呼吸三維延遲強(qiáng)化序列探測(cè)左室瘢痕的臨床應(yīng)用[A];中國心臟大會(huì)(CHC)2011暨北京國際心血管病論壇論文集[C];2011年
相關(guān)碩士學(xué)位論文 前3條
1 蘭天;對(duì)比增強(qiáng)磁共振對(duì)缺血性心臟病與原發(fā)性擴(kuò)張型心肌病的臨床鑒別研究[D];北京協(xié)和醫(yī)學(xué)院;2014年
2 徐剛;心臟磁共振在肥厚型心肌病中的臨床應(yīng)用研究[D];第三軍醫(yī)大學(xué);2015年
3 白若冰;MR彌散加權(quán)成像在延遲強(qiáng)化肝臟惡性腫瘤中的應(yīng)用[D];中國醫(yī)科大學(xué);2010年
,本文編號(hào):1530580
本文鏈接:http://sikaile.net/yixuelunwen/fangshe/1530580.html